Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWOmeprazole is an inhibitor of gastric H+/K+ ATPase (IC50 = 1.1 µM for the pig ATPase).1 It is a racemic mixture of esomeprazole (Item No. 17303) and (R)-omeprazole (Item No. 18874).2 Omeprazole (100 µM) decreases zymosan-induced oxygen free radical production in isolated human neutrophils.3 It is active against 17 strains of H. pylori (MIC50s = 12.5-50 µg/ml).4 It decreases histamine-induced acid secretion in dogs (ED50 = 0.35 µmol/kg).5 Formulations containing omeprazole have been used in the treatment of duodenal and gastric ulcers, gastroesophageal reflux disease, and erosive esophagitis.
WARNING This product is not for human or veterinary use.
1. Inhibition of gastric H,K-
2. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-
3. Omeprazole attenuates oxygen-
4. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob. Agents Chemother. 35(3), 490-496 (1991).
5. Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology 85(4), 900-907 (1983).
Gastric acid secretion from parietal cells is mediated by a Ca2+ efflux channel in the tubulovesicle. Dev. Cell 41(3), 262-273 (2017).